GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (OTCPK:CZMWF) » Definitions » 3-Year EPS without NRI Growth Rate

Carl Zeiss Meditec AG (Carl Zeiss Meditec AG) 3-Year EPS without NRI Growth Rate : 33.40% (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Carl Zeiss Meditec AG 3-Year EPS without NRI Growth Rate?

Carl Zeiss Meditec AG's EPS without NRI for the three months ended in Dec. 2023 was $0.46.

During the past 12 months, Carl Zeiss Meditec AG's average EPS without NRI Growth Rate was -9.60% per year. During the past 3 years, the average EPS without NRI Growth Rate was 33.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was 21.00% per year. During the past 10 years, the average EPS without NRI Growth Rate was 13.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Carl Zeiss Meditec AG was 33.40% per year. The lowest was -8.90% per year. And the median was 9.95% per year.


Competitive Comparison of Carl Zeiss Meditec AG's 3-Year EPS without NRI Growth Rate

For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carl Zeiss Meditec AG's 3-Year EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Carl Zeiss Meditec AG's 3-Year EPS without NRI Growth Rate falls into.



Carl Zeiss Meditec AG 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Carl Zeiss Meditec AG  (OTCPK:CZMWF) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Carl Zeiss Meditec AG 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Carl Zeiss Meditec AG's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Carl Zeiss Meditec AG (Carl Zeiss Meditec AG) Business Description

Address
Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Carl Zeiss Meditec is one of the largest medical technology companies in the world and it operates in two segments: Ophthalmic devices and Microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.